StockData
CNBX Pharmaceuticals Inc. logo

CNBX Pharmaceuticals Inc. (CNBX) stock

CNBXOTCPharmaceutical PreparationsFiscal year ends August 31
Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026Score 0/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $197.79KP/E –Yield –

CNBX Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CNBX Pharmaceuticals's price to book ratio was 1.4× on Dec 30, 2022, against 300.2× a year earlier.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2022Dec 30, 20221.4×−477.6
2020Mar 31, 2020479.0×+345.0
2019Dec 31, 2019134.0×–

More CNBX Pharmaceuticals figures

See a number that looks wrong?